Dopaminergic synapse, action of dopaminergic agonists, COMT inhibitors, and MAO-B. Treatments for Parkinson's disease are aimed at increasing the level of dopamine in the synaptic cleft. (Photo by: ...

Much has been written about the subunit composition of hippocampal NMDA receptors and their differential contributions to functions ranging from learning to neurodegeneration. Although NMDA receptors ...